• OPEN AN ACCOUNT
Indian Indices
Sensex
84,187.66 121.91
( 0.15%)
Global Indices
Nasdaq
50,149.26 12.58
(0.03%)
Dow Jones
6,984.17 30.87
(0.44%)
Hang Seng
57,678.97 1,315.03
(2.33%)
Nikkei 225
10,364.03 -5.72
(-0.06%)
Forex
USD-INR
90.44 0.11
(0.13%)
EUR-INR
106.84 0.33
(0.31%)
GBP-INR
123.03 0.35
(0.29%)
JPY-INR
0.58 0.00
(-0.07%)

EQUITY - MARKET SCREENER

Gufic BioSciences Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
509079
INE742B01025
62.6776943
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
GUFICBIO
57.65
3133.33
EPS(TTM)
Face Value()
Div & Yield %
5.42
1
0.03
 

Brigade Ent acquires 4 acre land parcel in Hyderabad auction
Dec 04,2025
The land was purchased at a consideration of Rs 118 crore per acre.

This acquisition follows the company’s earlier acquisition in the same micro-market, where it is currently developing Brigade Gateway (Plot No. 8), Hyderabad. The move reinforces Brigade’s strategic growth plans in the city.

Amar Mysore, executive director, Brigade Enterprises, said, “Hyderabad is a key market in our expansion strategy, Around this time last year, we launched Brigade Gateway in Neopolis — a premium mixed-use development inspired by our iconic Bengaluru project, bringing together all key asset classes including Orion Mall, World Trade Center Hyderabad, a five-star deluxe InterContinental hotel, and high-end residences supported by a well-appointed clubhouse. With a robust pipeline of projects planned for Hyderabad, this acquisition underscores our commitment to investing in high-potential locations and delivering well-designed, future-ready developments for discerning customers.”

Brigade Enterprises is one of India’s leading property developers. The company has developed properties in cities like Bengaluru, Chennai, Hyderabad, Mysuru, Kochi, Gift City-Gujarat, Thiruvananthapuram, Mangaluru and Chikkamagaluru with developments across residential, office, retail and hotels.

The company had reported 36.57% jump in consolidated net profit to Rs 162.50 crore in Q2 FY26 as against Rs 118.98 crore reported in Q2 FY25. Revenue from operations grew 29.02% YoY to Rs 1,383.37 crore in the quarter ended 30 September 2025.

The counter rose 0.47% to Rs 890 on the BSE.